Pill
Latest Pfizer Inc. Patents:
- Dosing Regime For Treatment of Chronic Hand Eczema
- Crystalline form of (2R)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2S)-7-methyl-6-(pyrimidin-2-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3-pyrrolidin]-1-yl]propan-1-one
- Combinations for treatment of NASH/NAFLD and related diseases
- Amorphous Form of (S)-2-(5-((3-Ethoxypyridin-2-YL)Oxy)Pyridin-3-YL)-N-(Tetrahydrofuran-3-YL)Pyrimidine-5-Carboxamide
- Glycoconjugation process
Description
The shading in the figures are for illustrative purposes only and form no part of the claimed design.
Claims
The ornamental design for a pill, as shown and described.
Referenced Cited
U.S. Patent Documents
D359554 | June 20, 1995 | Dansereau |
D425614 | May 23, 2000 | Chen |
D430285 | August 29, 2000 | Chen |
D431076 | September 19, 2000 | Chen |
D434846 | December 5, 2000 | Chen |
D500849 | January 11, 2005 | Rinker |
D506544 | June 21, 2005 | Rinker |
D515202 | February 14, 2006 | Chen |
D534646 | January 2, 2007 | Chang |
D631537 | January 25, 2011 | Sadler |
D773641 | December 6, 2016 | Sadler |
D835257 | December 4, 2018 | Parikh |
D858741 | September 3, 2019 | Parikh |
D907760 | January 12, 2021 | Hassan |
Patent History
Patent number: D1017017
Type: Grant
Filed: Dec 20, 2021
Date of Patent: Mar 5, 2024
Assignee: Pfizer Inc. (New York, NY)
Inventors: Patrick David Daugherity (Niantic, CT), Weili Yu (Pawcatuck, CT), Daniel R. Arenson (Lake Oswego, OR)
Primary Examiner: Charles D Hanson
Application Number: 29/820,186
Type: Grant
Filed: Dec 20, 2021
Date of Patent: Mar 5, 2024
Assignee: Pfizer Inc. (New York, NY)
Inventors: Patrick David Daugherity (Niantic, CT), Weili Yu (Pawcatuck, CT), Daniel R. Arenson (Lake Oswego, OR)
Primary Examiner: Charles D Hanson
Application Number: 29/820,186
Classifications
Current U.S. Class:
Tablet Or Caplet (1) (D24/101)